INNEO is a peptide-based antimicrobial processing aid. USDA’s No Objection Letter enables U.S. meat and poultry processors to use INNEO both as a surface treatment and directly within the food matrix of comminuted products.
A new study estimates the annual cost of foodborne illness in Australia from six important pathogens to be $721 million AUD, with nearly half of this cost ($328 million AUD) attributed to poultry sources.
University of Georgia researchers conducted a review to compile and communicate best practices for reducing the spread of foodborne pathogens among beef cattle herds prior to processing, with a focus on Shiga toxin-producing Escherichia coli.
Following the withdrawal of the previously proposed strategy for reducing Salmonella in poultry, USDA-FSIS will host a public meeting on January 14 to advance work on a new approach, facilitating a discussion on “practical strategies” that “reflect both public health goals and industry realities.”
The sampling and testing project will support the National Antimicrobial Resistance Monitoring System (NARMS) by identifying trends and emerging risks from drug-resistant foodborne bacteria. Findings will be used to create a model that can help predict and address antimicrobial resistance (AMR) mitigation strategies.
This episode of Food Safety Five discusses a farm-to-fork quantitative microbial risk assessment (QMRA) for Listeria monocytogenes in cantaloupe, a study demonstrating the efficacy of antimicrobial peptides for reducing Salmonella in poultry, and the adoption of new international standards at the 48th session of the Codex Alimentarius Commission.
After withdrawing its previously proposed regulatory framework for Salmonella in raw poultry in April, USDA-FSIS is indefinitely delaying verification activities for Salmonella in not-ready-to-eat, breaded and stuffed chicken products, and is reconsidering its strategy to reduce Salmonella in poultry with an exploratory public meeting in January.
Health Canada has determined that foods derived from cloned cattle and swine are safe and should no longer be considered novel foods, and has proposed policy revisions that would regulate these foods in the same manner as their traditional counterparts.
A letter sent to FDA urges the agency to immediately withdraw its approval of Carbadox, a carcinogenic swine feed additive. FDA’s proposal to withdraw Carbadox approvals has been pending for two years, during which time there has not been an approved method for detecting Carbadox residue in pork.
A new study has demonstrated that antimicrobial peptides derived from Lactobacillus rhamnosus can effectively reduce Salmonella in chickens under industry-relevant conditions. Adoption of the novel intervention could potentially help mitigate the growing public health threat that is antimicrobial resistance (AMR).
RSS
